SBFM (Sunshine Biopharma, Inc.) Earnings per share growth rate in current year
Sunshine Biopharma (SBFM) minimizes capital expenditures by outsourcing production in the US and Canada. The relative annual earnings per share growth on the GURU.Markets daily price chart reflects yield dynamics, where the 87.00 mark records this metric. Controlled laboratory expenses and sufficient cash provide stability, while future price potential is driven by oncology drug patents.
Analytical breakdowns and data insights for company sunshinebiopharma.com (SBFM)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Debt to Equity Ratio Sunshine Biopharma|SBFM - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Sunshine Biopharma, Inc.|SBFM - Company Aggregate Debts|Debt to Net Assets Ratio Sunshine Biopharma|SBFM - Company Long-Term Debts|Short-Term Debt Volume Sunshine Biopharma|Immediate Liquidity Ratio sunshinebiopharma.com
- earnings and multiples data:
SBFM - Net Profit|Expected Net Profit Sunshine Biopharma|SBFM - Price to Earnings Ratio|Future Price to Earnings Multiple Sunshine Biopharma|SBFM - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sunshine Biopharma|SBFM - Operating profit EBITDA|Net earnings per share for the last four quarters Sunshine Biopharma|SBFM - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sunshinebiopharma.com|SBFM - Earnings per share growth in current year|Net earnings per share change forecast for next year Sunshine Biopharma
- company sales and revenue statistics:
Fundamental valuation:Sunshine Biopharma (SBFM)
The efficiency of recruiting leading oncologists at Sunshine Biopharma (SBFM) directly impacts capitalization through the intellectual potential of its developments. The eps_yy_co metric digitizes the dynamics of net income per share, comparing current results with the same period last year to identify the real profitability trend. Analyzing the annual earnings per share growth rate allows for the filtering of transaction volatility and an assessment of the business's fundamental stability.
Direct competitors
Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings per share growth in current year UroGen URGN|Expected net earnings per share growth this year Bicara Bio (BCAX)|PSNL - Earnings per share growth in current year|ERAS - Earnings growth in current year|DCTH: Earnings growth in current year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth in current year|Net earnings per share growth this year AURA|Earnings per share growth rate in current year candeltx.com CADL|Earnings growth in current year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Earnings per share increase in current year|Earnings growth in current year ACTU (Actuate Therapeutics Inc)|Earnings per share increase in current year CTOR|tuhurabio.com - Earnings growth in current year|Earnings per share increase in current year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Earnings per share growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year tscan.com|CSBR: Earnings per share increase in current year|Earnings per share growth in current year XBiotech USA (XBIT)|CVM: Earnings per share trend in current year|Earnings per share growth in current year ostherapies.com OSTX|Net earnings per one share growth for the current year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth in current year|ANL: Earnings per share growth in current year|VERU: Earnings growth in current year|Earnings per share trend in current year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth in current year|Earnings per share growth rate in current year renovarobio.com RENB|Earnings per share growth in current year muraloncology.com (MURA)|Net earnings per one share growth for the current year KAPA|Earnings growth in current year OKUR (onkuretherapeutics.com)|Net earnings per one share growth for the current year GDTC (CytoMed)|Curis - Earnings growth in current year|APLM: Earnings per share growth in current year|Tharimmune (THAR) - Earnings per share growth in current year|Net earnings per share growth this year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth in current year|Calidi Biotherapeutics (CLDI) - Expected net earnings per share growth this year|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharmaceuticals SLRX|Earnings growth in current year PPBT (Purple Biotech Ltd)|AONC - Net earnings per share growth this year|BGNE: Net earnings per share growth this year|Expected net earnings per share growth this year Checkpoint Therapeutics, Inc CKPT|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma
